Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : AbbVie Stemcentrx LLC

Femme et Homme Max 99 ans
AbbVie Stemcentrx LLC MAJ Il y a 4 ans

A Clinical Trial to observe the effects of the test drug Rovalpituzumab Tesirine in patients with a particular form of Lung Cancer where no lasting efficacy has been achieved on at least two previous therapies To investigate the efficacy of rovalpituzumab tesirine as third-line and later treatment for subjects with relapsed or refractory delta-like protein 3 (DLL3)-expressing small cell lung cancer (SCLC)

Pays Aucun
Organes Aucun
Spécialités Aucune

unknown

Plus d'informations